Cargando…

Insertion of an Amphipathic Linker in a Tetrapodal Tryptophan Derivative Leads to a Novel and Highly Potent Entry Inhibitor of Enterovirus A71 Clinical Isolates

AL-471, the leading exponent of a class of potent HIV and enterovirus A71 (EV-A71) entry inhibitors discovered in our research group, contains four l-tryptophan (Trp) units bearing an aromatic isophthalic acid directly attached to the C2 position of each indole ring. Starting from AL-471, we (i) rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martí-Marí, Olaia, Abdelnabi, Rana, Schols, Dominique, Neyts, Johan, Camarasa, María-José, Gago, Federico, San-Félix, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959982/ https://www.ncbi.nlm.nih.gov/pubmed/36834952 http://dx.doi.org/10.3390/ijms24043539

Ejemplares similares

Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors†
por: Martí-Marí, Olaia, et al.
Publicado: (2021)

Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors
por: Ruiz‐Santaquiteria, Marta, et al.
Publicado: (2021)

Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum
por: Martínez-Gualda, Belén, et al.
Publicado: (2019)

Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid
por: Sun, Liang, et al.
Publicado: (2019)

Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry
por: Xu, Fengwen, et al.
Publicado: (2016)

A tradeoff between enterovirus A71 particle stability and cell entry
por: Catching, Adam, et al.
Publicado: (2023)

Receptors for enterovirus 71
por: Yamayoshi, Seiya, et al.
Publicado: (2014)

Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71
por: Zhu, Ling, et al.
Publicado: (2018)

Enterovirus 71 Outbreak, Brunei
por: AbuBakar, Sazaly, et al.
Publicado: (2009)

Recombinant Human Enterovirus 71
Publicado: (2004)

The cellular receptor for enterovirus 71
por: Liu, Yue, et al.
Publicado: (2014)

Enterovirus 71 infection and vaccines
por: Yi, Eun-Je, et al.
Publicado: (2017)

Enterovirus A71 Vaccines
por: Li, Mei-Ling, et al.
Publicado: (2021)

Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy
por: Tsou, Yueh-Liang, et al.
Publicado: (2013)

Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005)

Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases
por: Yuan, Meichun, et al.
Publicado: (2018)

Cell and tissue tropism of enterovirus 71 and other enteroviruses infections
por: Lin, Jing-Yi, et al.
Publicado: (2014)

Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71
por: Chen, Zhe, et al.
Publicado: (2022)

Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells
por: Chen, Sheng-Lin, et al.
Publicado: (2019)

Isolation and Characterization of scFv Antibody against Internal Ribosomal Entry Site of Enterovirus A71
por: Hlaing, Su Thandar, et al.
Publicado: (2023)

COPI Is Required for Enterovirus 71 Replication
por: Wang, Jianmin, et al.
Publicado: (2012)

Seroepidemiology of Human Enterovirus 71, Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2002)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

112 The Development of Enterovirus 71 Vaccine
por: Xiuling, Li, et al.
Publicado: (2014)

Enterovirus 71 infection and neurological complications
por: Lee, Kyung Yeon
Publicado: (2016)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Cellular receptors for enterovirus A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2020)

Adaptation and Virulence of Enterovirus-A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2021)

Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide
por: Zhu, Xin, et al.
Publicado: (2014)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Daphne Genkwa Sieb. et Zucc. Water-Soluble Extracts Act on Enterovirus 71 by Inhibiting Viral Entry
por: Chang, Chia-Wen, et al.
Publicado: (2012)

Polypyrimidine Tract-Binding Protein Regulates Enterovirus 71 Translation Through Interaction with the Internal Ribosomal Entry Site
por: Xi, Juemin, et al.
Publicado: (2019)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
por: Shi, Jingru, et al.
Publicado: (2021)

Protein Amphipathic Helix Insertion: A Mechanism to Induce Membrane Fission
por: Zhukovsky, Mikhail A., et al.
Publicado: (2019)

Sentinel surveillance for enterovirus 71, Taiwan, 1998.
por: Wu, T N, et al.
Publicado: (1999)

Enterovirus 71 Maternal Antibodies in Infants, Taiwan
por: Luo, Shu-Ting, et al.
Publicado: (2009)

Molecular Analysis of Virulent Determinants of Enterovirus 71
por: Li, Renqing, et al.
Publicado: (2011)

Enterovirus 71 Outbreaks, Taiwan: Occurrence and Recognition
por: Lin, Tzou-Yien, et al.
Publicado: (2003)

Enterovirus 71 infection: An experience in Korea, 2009
por: Kim, Kyung Hyo
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lomh1q04sabforfjd72pdb3pj9